capecitabine winthrop
sanofi-aventis new zealand limited - capecitabine 150mg - film coated tablet - 150 mg - active: capecitabine 150mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine winthrop is indicated for the treatment of patients with locally advanced or / metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated. capecitabine winthrop in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.
capecitabine winthrop
sanofi-aventis new zealand limited - capecitabine 500mg - film coated tablet - 500 mg - active: capecitabine 500mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine winthrop is indicated for the treatment of patients with locally advanced or / metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated. capecitabine winthrop in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.
capercit
dr reddy's new zealand limited - capecitabine 150mg - film coated tablet - 150 mg - active: capecitabine 150mg excipient: croscarmellose sodium hypromellose opadry pink 03a540004 lactose magnesium stearate microcrystalline cellulose - capercit tablets are indicated for the adjuvant treatment of patients with dukes stage c and higher-risk stage b colon cancer, either as monotherapy or in combination with oxaloplatin
capercit
dr reddy's new zealand limited - capecitabine 500mg - film coated tablet - 500 mg - active: capecitabine 500mg excipient: croscarmellose sodium hypromellose opadry pink 03a540003 lactose magnesium stearate microcrystalline cellulose - capercit tablets are indicated for the adjuvant treatment of patients with dukes stage c and higher-risk stage b colon cancer, either as monotherapy or in combination with oxaloplatin
go mussel 19,000 new zealand green lipped
the better health company (australia) pty - green lipped mussel dried -
shirlan
isk new zealand limited - fluazinam - fluazinam 500 g/litre - fungicide
healtheries new zealand digestive enzyme complex
vitaco health australia pty ltd - amylase,bromelains,lipase,papain,piper longum,piper nigrum,protease,tilactase,zingiber officinale -
healtheries new zealand calcium advanced plus vitamin d
vitaco health australia pty ltd - colecalciferol,equisetum arvense,hydroxyapatite,magnesium oxide,manganese amino acid chelate,phytomenadione,zinc gluconate -
healtheries new zealand kids omega bites
vitaco health australia pty ltd - concentrated fish omega-3 triglycerides -
healtheries new zealand celery forte 10,000
vitaco health australia pty ltd - apium graveolens -